U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H24O2
Molecular Weight 284.3927
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BOLDIONE

SMILES

C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O

InChI

InChIKey=LUJVUUWNAPIQQI-QAGGRKNESA-N
InChI=1S/C19H24O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h7,9,11,14-16H,3-6,8,10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1

HIDE SMILES / InChI

Molecular Formula C19H24O2
Molecular Weight 284.3927
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Boldione, also known as androstadienedione or 1-dehydroandrostenedione, as well as 1,4-androstadiene-3,17-dione, is an important industrial precursor for various steroid hormones. Boldione is a direct precursor (prohormone) to the anabolic steroid boldenone (1,4-androstadiene-17beta-ol-3-one). It is advertised as a highly anabolic/androgenic compound promoting muscularity, enhancing strength and overall physical performance, and is available on the Internet and in health stores. Boldione was marketed as a prohormone “dietary supplement” for many years in the mid-2000’s, but it is truly a potent precursor (ie. converts in the body) to the anabolic steroid Boldenone. In 2005 the Anabolic Steroid Control Act of 2005 classified boldenone as a Schedule III controlled illegal steroid.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
120.0 nM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Polycations increase the permeability of Mycobacterium vaccae cell envelopes to hydrophobic compounds.
2001 Oct
Bioconversion of 3 beta-acetoxypregna-5,16-diene-20-one to androsta-1,4-diene-3,17-dione by mixed bacterial culture.
2002
Testosterone metabolism in the estuarine mysid neomysis integer (Crustacea; Mysidacea): identification of testosterone metabolites and endogenous vertebrate-type steroids.
2002 Apr
Isolation of a biodegradable sterol-rich fraction from industrial wastes.
2002 May
Studies on the catalytic function of aromatase: aromatization of 6-alkoxy-substituted androgens.
2002 Sep
Resistance to androstanes as an approach for androstandienedione yield enhancement in industrial mycobacteria.
2003 Oct
Analytical strategies for the detection of non-labelled anabolic androgenic steroids in nutritional supplements.
2004 Jul
[Conversion of androstenedione and androstadienedione by sterol-degrading bacteria].
2004 Sep-Oct
The effect of ethambutol on mycobacterial cell wall permeability to hydrophobic compounds.
2005
ADD, AED, alpha-boldenone and epitestosterone neo formation in calf faeces: preliminary results.
2005 Aug
Persistence and pathways of testosterone dissipation in agricultural soil.
2005 May-Jun
C19-steroids as androgen receptor modulators: design, discovery, and structure-activity relationship of new steroidal androgen receptor antagonists.
2006 Sep 1
Effect of anabolics on bovine granulosa-luteal cell primary cultures.
2007
An in vitro study on metabolism of 17beta-boldenone and boldione using cattle liver and kidney subcellular fractions.
2007 Mar 14
[Preparation of androsta-1,4-diene-3,17-dione from sterols using Mycobacterium neoaurum VKPM As-1656 strain].
2007 May-Jun
Boldenone, boldione, and milk replacers in the diet of veal calves: the effects of phytosterol content on the urinary excretion of boldenone metabolites.
2007 Oct 3
Development of a rapid normal-phase LC-positive ion APCI-MS method for simultaneous detection and quantitation of cholesterol, androst-4-ene-3,1 7-dione, and androsta-1,4-diene-3,17-dione.
2007 Sep
Evaluation of boldenone formation and related steroids transformations in veal faeces by liquid chromatography/tandem mass spectrometry.
2008
Enhancement of androstadienedione production from progesterone by biotransformation using the hydroxypropyl-beta-cyclodextrin complexation technique.
2008 Jan
Boldenone, testosterone and 1,4-androstadiene-3,17-dione determination in faeces from horses, untreated and after administration of androsta-1,4-diene-3,17-dione (boldione).
2008 Jun
Naturally occurring progesterone in loblolly pine (Pinus taeda L.): a major steroid precursor of environmental androgens.
2008 Jun
Comprehensive screening of acidic and neutral drugs in equine plasma by liquid chromatography-tandem mass spectrometry.
2008 May 2
Cholesterol oxidase: physiological functions.
2009 Dec
Classification of three steroids as schedule III anabolic steroids under the Controlled Substances Act. Final rule.
2009 Dec 4
Excretion of endogenous boldione in human urine: influence of phytosterol consumption.
2009 Oct
Investigation on possible transformations of cortisol, cortisone and cortisol glucuronide in bovine faecal matter using liquid chromatography-mass spectrometry.
2010 Apr
Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids.
2010 Apr
Characterisation of steroids in wooden crates of veal calves by accelerated solvent extraction (ASE) and ultra-high performance liquid chromatography coupled to triple quadrupole mass spectrometry (U-HPLC-QqQ-MS-MS).
2010 May
Cholesterol utilization in mycobacteria is controlled by two TetR-type transcriptional regulators: kstR and kstR2.
2010 May
Cholesterol biotransformation to androsta-1,4-diene-3,17-dione by growing cells of Chryseobacterium gleum.
2010 May
Primary hepatocytes as an useful bioassay to characterize metabolism and bioactivity of illicit steroids in cattle.
2012 Oct
Patents

Sample Use Guides

2-4 pills (400-800mg) a day.
Route of Administration: Oral
In Vitro Use Guide
Boldione inhibited Cytochrome P450 19A1 in human placental microsomes with the IC50 value of 530 nM.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:58:37 GMT 2025
Edited
by admin
on Mon Mar 31 18:58:37 GMT 2025
Record UNII
2166Q8568W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BOLDIONE
Common Name English
EXEMESTANE RELATED COMPOUND C CIII
USP-RS  
Preferred Name English
ANDROSTADIENEDIONE
Systematic Name English
1-DEHYDROANDROSTENEDIONE
Common Name English
ANDROSTA-1,4-DIEN-3,17-DIONE
Systematic Name English
TESTOSTERONE IMPURITY G [EP IMPURITY]
Common Name English
.DELTA.1,4-ANDROSTADIENE-3,17-DIONE
Common Name English
(+)-ANDROSTA-1,4-DIENE-3,17-DIONE
Systematic Name English
EXEMESTANE IMPURITY D [EP IMPURITY]
Common Name English
Androsta-1,4-diene-3,17-dione
Systematic Name English
J38.935H
Code English
1,4-ANDROSTADIENE-3,17-DIONE
Systematic Name English
NSC-49080
Code English
ANDROSTANE-1,4-DIENE-3,17-DIONE
Systematic Name English
EXEMESTANE RELATED COMPOUND C [USP-RS]
Common Name English
Classification Tree Code System Code
DEA NO. 4000
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
Code System Code Type Description
ECHA (EC/EINECS)
212-977-2
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
EVMPD
SUB194899
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
WIKIPEDIA
BOLDIONE
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
RS_ITEM_NUM
1269083
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
EPA CompTox
DTXSID00862463
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
NSC
49080
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
PUBCHEM
13472
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
SMS_ID
100000181312
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
MESH
C006573
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
FDA UNII
2166Q8568W
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
CAS
897-06-3
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
CHEBI
40799
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
DRUG BANK
DB07373
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP